Peysh A Patel Selected Research

Insulin Resistance

11/2017

Endothelial SHIP2 Suppresses Nox2 NADPH Oxidase-Dependent Vascular Oxidative Stress, Endothelial Dysfunction, and Systemic Insulin Resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peysh A Patel Research Topics

Disease

7	Heart Failure 01/2021 - 01/2016
3	Left Ventricular Dysfunction 10/2018 - 01/2016
1	COVID-19 01/2021
1	Heart Arrest (Cardiac Arrest) 08/2020
1	Pathologic Constriction (Stenosis) 01/2019
1	Sepsis (Septicemia) 10/2018
1	Chronic Obstructive Pulmonary Disease (COPD) 10/2018
1	Atrial Fibrillation 10/2018
1	Aortic Valve Stenosis (Aortic Stenosis) 01/2018
1	Insulin Resistance 11/2017
1	Inflammation (Inflammations) 07/2017
1	Malnutrition (Nutritional Deficiencies) 07/2017
1	Cardiac Arrhythmias (Arrythmia) 01/2017
1	Diabetes Mellitus 01/2016

Drug/Important Bio-Agent (IBA)

1	Vitamin D FDA LinkGeneric 10/2018
1	IvabradineIBA 01/2018
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2018
1	NADPH Oxidases (NAD(P)H oxidase)IBA 11/2017
1	ProlactinIBA 07/2017
1	Amiodarone (Amiodarona)FDA LinkGeneric 01/2017
1	DiureticsIBA 01/2016

Therapy/Procedure

6	Therapeutics 01/2021 - 01/2016
2	Drug Therapy (Chemotherapy) 07/2017 - 01/2017
1	Cardiopulmonary Resuscitation (CPR) 01/2021
1	Emergency Treatment 08/2020
1	Percutaneous Coronary Intervention 01/2019
1	Catheter Ablation 10/2018
1	Transcatheter Aortic Valve Replacement 01/2018
1	Defibrillators (Defibrillator) 01/2016
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2016